Trials / Conditions / Resectable Carcinoma
Resectable Carcinoma
3 registered clinical trials studyying Resectable Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer NCT05802407 | Peking Union Medical College Hospital | N/A |
| Active Not Recruiting | Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluoroura NCT04736485 | Centre Francois Baclesse | Phase 2 |
| Active Not Recruiting | Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy NCT04554771 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 2 |